BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18636211)

  • 1. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
    Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
    Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.
    Farnebo L; Jerhammar F; Ceder R; Grafström RC; Vainikka L; Thunell L; Grénman R; Johansson AC; Roberg K
    J Oral Pathol Med; 2011 Nov; 40(10):739-46. PubMed ID: 21481002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bcl-2 gene status of human head and neck cancer cell lines.
    Salo A; Servomaa K; Kiuru A; Pulkkinen J; Grénman R; Pekkola-Heino K; Rytömaa T
    Acta Otolaryngol Suppl; 1997; 529():233-6. PubMed ID: 9288319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
    Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
    Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status.
    Oya N; Zölzer F; Werner F; Streffer C
    Strahlenther Onkol; 2003 Feb; 179(2):99-106. PubMed ID: 12590320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors.
    Roberg K; Jonsson AC; Grénman R; Norberg-Spaak L
    Head Neck; 2007 Apr; 29(4):325-34. PubMed ID: 17163470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck.
    Sheridan MT; O'Dwyer T; Seymour CB; Mothersill CE
    Radiat Oncol Investig; 1997; 5(4):180-6. PubMed ID: 9327497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
    Brachman DG; Beckett M; Graves D; Haraf D; Vokes E; Weichselbaum RR
    Cancer Res; 1993 Aug; 53(16):3667-9. PubMed ID: 8339273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
    Yamazaki Y; Chiba I; Hirai A; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Iizuka T; Kohgo T; Fukuda H
    Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
    Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
    Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
    Hoffmann TK; Sonkoly E; Hauser U; van Lierop A; Whiteside TL; Klussmann JP; Hafner D; Schuler P; Friebe-Hoffmann U; Scheckenbach K; Erjala K; Grénman R; Schipper J; Bier H; Balz V
    Oral Oncol; 2008 Dec; 44(12):1100-9. PubMed ID: 18487078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.